Dogwood Therapeutics
DWTX
20 hedge funds and large institutions have $493K invested in Dogwood Therapeutics in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.16% more ownership
Funds ownership: 4.31% → 4.47% (+0.16%)
13% less funds holding
Funds holding: 23 → 20 (-3)
36% less capital invested
Capital invested by funds: $766K → $493K (-$273K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$130K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$5.59K |
| 3 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
+$2.49K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.75K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$1.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$95.2K |
| 2 |
VF
Virtu Financial
New York
|
-$25K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$20.9K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$10K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$9.32K |
DWTX Hedge Fund Activity: Q4 2023 in Review
20 of the 6,870 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q4 2023, worth a combined $493K — down 36% from $766K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DWTX and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $130K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $95.2K sold.
- 20 institutional investors held Dogwood Therapeutics (DWTX) as of Q4 2023, down from 23 in Q3 2023.
- Funds reported $493K of Dogwood Therapeutics stock for Q4 2023, down 36% quarter-over-quarter.
- 1 fund opened new Dogwood Therapeutics positions in Q4 2023 and 4 closed out, a net change of -3 holders.
- The largest Dogwood Therapeutics buyer in Q4 2023 was Renaissance Technologies, an estimated $130K added.
- The largest Dogwood Therapeutics seller in Q4 2023 was Susquehanna International Group, an estimated $95.2K sold.
Based on aggregated 13F filings for Q4 2023.